Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BSAVA PetSavers awards Clinical Research Project grants
The University of Cambridge will use its grant to examine glaucoma in Welsh springer spaniels.
Eight projects have received funding, totalling nearly £110,000.

The British Small Animal Veterinary Association (BSAVA) has announced the eight Clinical Research Projects in receipt of its BSAVA PetSavers grants.

The Grants Awarding Committee has awarded a total of nearly £110,000 to small-scale research projects, including four projects jointly funded by affiliate groups.

BSAVA’s Clinical Research Project grants are intended to support research to advance understanding of the causes and management of clinical disorders. Its latest funding supports research covering genetics, microbiology and innovative diagnostics.

One such project is being conducted by researchers at the University of Cambridge, which are hoping to identify the genetic risk factors for glaucoma in Welsh springer spaniels.

A research team at the Royal Veterinary College will use its grant to tackle antifungal drug resistance linked to canine Malassezia pachydermatis. This could inform therapeutic choices and drug stewardship.

The University of Glasgow will investigate how saliva can be used to monitor canine epilepsy, and the University of Edinburgh will consider links between the gut microbiome and autoimmune disease in dogs.

Among those receiving joint funding are AURA Veterinary and the University of Surrey, which is awarded funding from both PetSavers and the Small Animal Medicine Society. The team will investigate small-RNA sequencing profiles in dogs with prostatic carcinoma, as they seek to develop a minimally invasive diagnostic tool.

The British Veterinary Neurology Society has contributed to a project at the University of Glasgow, which is considering how far artificial intelligence can detect tonic-clonic seizures.

Meanwhile the Veterinary Cardiovascular Society has contributed funding to two projects.

The first research project will see Bristol Vet Specialists and the University of Cambridge collaborate with Great Ormond Street Hospital. They will use a micro-CT to explore how the prevalence of congenital heart disease may explain the deaths of neonatal puppies.

The second project will examine acute phase protein concentrations in canine pericardial effusions at Willows Veterinary Centre.

Sarah Williams, fundraising and grants awarding manager, said: “The applications were of a very high standard in this grant call, so our grants committee had some tough decisions to make, but we’re delighted to award funding to these new projects and look forward to the impact they will have on companion animal medicine.”

Image © el-ka/Shutterstock.com

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.